Adam Feuerstein ✡️
@adamfeuerstein
Biotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54
Friends - My humble request is that you sign up for the email version of my weekly newsletter. Its contents are also posted on STAT's website, but the email arrives every Thursday at 6:30 am ET which means you can hate-read it over coffee. statnews.com/signup/scoreca…
Replimune $REPL skin cancer therapy rejected by FDA The decision is another signal that the FDA’s top regulator of cell and gene therapies is taking a hardened stance on new drug approvals statnews.com/2025/07/22/rep…
Sanofi $SNY to buy vaccine biotech Vicebio for $1.15B upfront statnews.com/2025/07/22/san… via @DrewQJoseph
$SRPT With Elevidys paused, risk to balance sheet and solvency is an issue again. Obviously, will depend on how long Elevidys remains off the market, and whether Sarepta can restructure debt if necessary.
UPDATED: New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment statnews.com/2025/07/21/geo… via @statnews
The crisis over Sarepta’s $SRPT Duchenne therapy is a mess. But the lesson is clear statnews.com/2025/07/21/sar… via @matthewherper
Concentra Biosciences to acquire $ITOS for $10/share cash + CVR